메뉴 건너뛰기




Volumn 171, Issue 1, 2004, Pages 182-186

Clinical usefulness of serum antip53 antibodies for prostate cancer detection: A comparative study with prostate specific antigen parameters

Author keywords

Genes, p53; Prostate; Prostatic hyperplasia; Prostatic neoplasms; Tumor markers, biological

Indexed keywords

ANTIBODY; P53 ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 0347479286     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000101501.54931.4a     Document Type: Article
Times cited : (23)

References (20)
  • 2
    • 10244219862 scopus 로고    scopus 로고
    • Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer
    • Trivers, G. E., De Benedetti, V. M., Cawley, H. L., Caron, G., Harrington, A. M., Bennett, W. P. et al: Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res, 2: 1767, 1996
    • (1996) Clin Cancer Res , vol.2 , pp. 1767
    • Trivers, G.E.1    De Benedetti, V.M.2    Cawley, H.L.3    Caron, G.4    Harrington, A.M.5    Bennett, W.P.6
  • 3
    • 0037303696 scopus 로고    scopus 로고
    • Titration of serum p53 antibodies in 1085 patients with various cancers of malignant tumors: A multiinstitutional analysis by the Japan p53 Antibody Research Group
    • Shimada, H., Ochiai, T., Nomura, F. and Japan p53 Antibody Research Group: Titration of serum p53 antibodies in 1085 patients with various cancers of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. Cancer, 97: 682, 2003
    • (2003) Cancer , vol.97 , pp. 682
    • Shimada, H.1    Ochiai, T.2    Nomura, F.3
  • 4
    • 0033916382 scopus 로고    scopus 로고
    • Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
    • Catalona, W. J., Southwick, P. C., Slawin, K. M., Partin, A. W., Brawer, M. K., Flanigan, R. C. et al: Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology, 56: 255, 2000
    • (2000) Urology , vol.56 , pp. 255
    • Catalona, W.J.1    Southwick, P.C.2    Slawin, K.M.3    Partin, A.W.4    Brawer, M.K.5    Flanigan, R.C.6
  • 5
    • 0034663304 scopus 로고    scopus 로고
    • Prostate specific antigen adjusted for transition zone volume: The most powerful method for detecting prostate carcinoma
    • Kikuchi, E., Nakashima, J., Ishibashi, M., Ohigashi, T., Asakura, H., Tachibana, M. et al: Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma. Cancer, 89: 842, 2000
    • (2000) Cancer , vol.89 , pp. 842
    • Kikuchi, E.1    Nakashima, J.2    Ishibashi, M.3    Ohigashi, T.4    Asakura, H.5    Tachibana, M.6
  • 6
    • 0034048942 scopus 로고    scopus 로고
    • Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer
    • Brawer, M. K., Cheli, C. D., Neaman, I. E., Goldblatt, J., Smith, C., Schwartz, M. K. et al: Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol, 163: 1476, 2000
    • (2000) J Urol , vol.163 , pp. 1476
    • Brawer, M.K.1    Cheli, C.D.2    Neaman, I.E.3    Goldblatt, J.4    Smith, C.5    Schwartz, M.K.6
  • 7
    • 0033926763 scopus 로고    scopus 로고
    • Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer
    • Ito, K., Yamamoto, T., Kubota, Y., Suzuki, K., Fukabori, Y., Kurokawa, K. et al: Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology, 56: 278, 2000
    • (2000) Urology , vol.56 , pp. 278
    • Ito, K.1    Yamamoto, T.2    Kubota, Y.3    Suzuki, K.4    Fukabori, Y.5    Kurokawa, K.6
  • 8
    • 0020524559 scopus 로고
    • A method of comparing the areas under receiver operating characteristic curves derived from the same cases
    • Hanley, J. A. and McNeil, B. J.: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148: 839, 1983
    • (1983) Radiology , vol.148 , pp. 839
    • Hanley, J.A.1    McNeil, B.J.2
  • 9
    • 0025940113 scopus 로고
    • Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
    • Isaacs, W. B., Carter, B. S. and Ewing, C. M.: Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res, 51: 4716, 1991
    • (1991) Cancer Res , vol.51 , pp. 4716
    • Isaacs, W.B.1    Carter, B.S.2    Ewing, C.M.3
  • 10
    • 0029871033 scopus 로고    scopus 로고
    • Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer
    • Suzuki, H., Komiya, A., Aida, S., Ito, H., Yatani, R. and Shimazaki, J.: Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate, 28: 318, 1996
    • (1996) Prostate , vol.28 , pp. 318
    • Suzuki, H.1    Komiya, A.2    Aida, S.3    Ito, H.4    Yatani, R.5    Shimazaki, J.6
  • 12
    • 0028837632 scopus 로고
    • p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy
    • Bauer, J. J., Sesterhenn, I. A., Mostoffi, K. F., McLeod, D. G., Srivastava, S. and Moul, J. W.: p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. Clin Cancer Res, 1: 1295, 1995
    • (1995) Clin Cancer Res , vol.1 , pp. 1295
    • Bauer, J.J.1    Sesterhenn, I.A.2    Mostoffi, K.F.3    McLeod, D.G.4    Srivastava, S.5    Moul, J.W.6
  • 13
    • 0034667872 scopus 로고    scopus 로고
    • Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma
    • Shimada, H., Takeda, A., Arima, M., Okazumi, S., Matsubara, H., Nabeya, Y. et al: Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer, 89: 1677, 2000
    • (2000) Cancer , vol.89 , pp. 1677
    • Shimada, H.1    Takeda, A.2    Arima, M.3    Okazumi, S.4    Matsubara, H.5    Nabeya, Y.6
  • 14
    • 13144250129 scopus 로고    scopus 로고
    • Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: Correlation with clinicopathologic features and tumor markers
    • Shimada, H., Nakajima, K., Ochiai, T., Koide, Y., Okazumi, S. I., Matsubara, H. et al: Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers. Oncol Rep, 5: 871, 1998
    • (1998) Oncol Rep , vol.5 , pp. 871
    • Shimada, H.1    Nakajima, K.2    Ochiai, T.3    Koide, Y.4    Okazumi, S.I.5    Matsubara, H.6
  • 15
    • 0031964511 scopus 로고    scopus 로고
    • Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues
    • Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D. et al: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res, 58: 204, 1998
    • (1998) Cancer Res , vol.58 , pp. 204
    • Suzuki, H.1    Freije, D.2    Nusskern, D.R.3    Okami, K.4    Cairns, P.5    Sidransky, D.6
  • 16
    • 0034799615 scopus 로고    scopus 로고
    • Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer
    • Kito, H., Suzuki, H., Ichikawa, T., Sekita, N., Kamiya, N., Akakura, N. et al: Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer. Prostate, 49: 110, 2001
    • (2001) Prostate , vol.49 , pp. 110
    • Kito, H.1    Suzuki, H.2    Ichikawa, T.3    Sekita, N.4    Kamiya, N.5    Akakura, N.6
  • 17
    • 0030754058 scopus 로고    scopus 로고
    • Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases
    • Stapleton, A. M., Timme, T. L., Gousse, A. E., Li, Q. F., Tobon, A. A., Kattan, M. W. et al: Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. Clin Cancer Res, 3: 1389, 1997
    • (1997) Clin Cancer Res , vol.3 , pp. 1389
    • Stapleton, A.M.1    Timme, T.L.2    Gousse, A.E.3    Li, Q.F.4    Tobon, A.A.5    Kattan, M.W.6
  • 18
    • 0028874592 scopus 로고
    • Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma
    • Konishi, N., Hiasa, Y., Matsuda, H., Tao, M., Tsuzuki, T., Hayashi, I. et al: Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol, 147: 1112, 1995
    • (1995) Am J Pathol , vol.147 , pp. 1112
    • Konishi, N.1    Hiasa, Y.2    Matsuda, H.3    Tao, M.4    Tsuzuki, T.5    Hayashi, I.6
  • 19
    • 0034113998 scopus 로고    scopus 로고
    • p53 Antibodies in the sera of patients with various types of cancer: A review
    • Soussi, T.: p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res, 60: 1777, 2000
    • (2000) Cancer Res , vol.60 , pp. 1777
    • Soussi, T.1
  • 20
    • 0034056254 scopus 로고    scopus 로고
    • A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium
    • Fulmer, B. R. and Turner, T. T.: A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium. J Urol, 163: 1591, 2000
    • (2000) J Urol , vol.163 , pp. 1591
    • Fulmer, B.R.1    Turner, T.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.